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Canine lymphoma is one of the most commonly encountered neoplasms in veterinary 11 
medicine. This study aimed to identify the incidence, risk factors and presenting signs of 12 
lymphoma in dogs presenting to primary-care practice in the United Kingdom using analysis 13 




Case records from the VetCompassTM programme from primary-care practices in the UK were 18 
searched for newly diagnosed canine lymphoma cases within a one-year period, 2013. 19 
Diagnosis was based on clinical records with or without laboratory confirmation. Signalment 20 




There were 286 presumed newly-diagnosed cases identified during 2013 from 455,553 dogs 25 
(overall incidence risk 63/ 100,000 dogs/ year) of which 193 (67%) were laboratory confirmed 26 
(lab-confirmed incidence 42/ 100,000 dogs/ year). Advanced age; dogs older than 12 years, 27 
bodyweight; dogs greater than 30kg, and breed were significantly associated with lymphoma 28 
diagnosis. Only 18 dogs (6%) of the population identified were referred to a referral centre. 29 
 30 
Clinical Significance 31 
 32 
The incidence of canine lymphoma reported in this study is similar to that reported in previous 33 
studies looking at different populations of dogs. This study agrees with previous studies that 34 
age, bodyweight and breed are significant risk factors for lymphoma. Results of this study 35 
highlight the low number of cases with canine lymphoma referred within the population of 36 
the United Kingdom, emphasising the importance of research programmes like 37 




VetCompass, lymphoma, lymphosarcoma, first opinion, breed-associated risks, canine, dog 42 
 43 
Abbreviations 44 
CI – confidence interval 45 
EPR – electronic practice record 46 
IQR – interquartile range 47 
OR – odds ratio 48 
PARR – PCR for antigen receptor rearrangements 49 
XXX - XXXX XXXXX XXXX 50 
SD - standard deviation 51 
UK – United Kingdom 52 
LRT - likelihood ratio test 53 
 54 
  55 
Introduction 56 
 57 
Lymphoma is the most common malignant neoplasm of the canine haemopoetic system and 58 
is the most frequently medically-managed neoplasia in veterinary oncology (Zandvliet, 2016). 59 
Lymphoma is a general term that represents several different distinct forms of neoplastic 60 
lymphoid cells, many of which have been characterised based on anatomic location, 61 
histopathological appearance and immunophenotype (Valli, et al., 2013). The clinical 62 
presentation, molecular characteristics, treatment and response to treatment of canine 63 
multicentric lymphoma is similar to that reported for non-Hodgkin’s lymphoma in humans 64 
(Zandvliet, 2016). This makes lymphoma in dogs an attractive translational spontaneous 65 
model for study of lymphoma in humans.   66 
 67 
Previous studies have documented an incidence of between 7 to 107 cases per 100,000 dogs 68 
per year depending on the population of dogs being observed: either insured dogs or 69 
extrapolated from samples submitted to a pathology laboratory (Edwards, et al., 2003; Pastor, 70 
et al., 2009). In a questionnaire-based study examining cases presenting to primary-care 71 
practice within the UK, this number increased slightly to 122 cases per 100,000 dogs per year 72 
(Mellanby, et al., 2002).  73 
 74 
The incidence of canine lymphoma has been associated with increasing age with the most 75 
common occurrence in middle aged to older dogs (~6-9 years) (Edwards, et al., 2003). A more 76 
recent study of Australian dogs reported increased risk of diagnosing lymphoma in dogs over 77 
the age of 7 years (Yau, et al., 2017). 78 
 79 
Whilst sex and neutering status have not traditionally been associated with increased risk of 80 
lymphoma diagnosis, recent reports did find entire animals, particularly entire females under-81 
represented within the populations of animals studied. (Belanger, et al., 2017; Yau, et al., 82 
2017). 83 
 84 
Breed has been identified as a risk factor for diagnosis of naïve (not previously treated) 85 
lymphoma in dogs. Boxers, British bulldogs and bull mastiffs have all been reported with 86 
higher incidence of lymphoma (Edwards, et al., 2003), Australian cattle dogs, rottweilers and 87 
Doberman pinschers have also been reported at increased risk (Yau, et al., 2017). Golden 88 
retrievers were reported at increased risk in another study which also identified breed as a 89 
risk factor for diagnosis of lymphoma. This study also looked at immunophenotype and 90 
recorded that cocker spaniels and basset hounds appeared predisposed to B cell lymphoma 91 
whilst shih-tzus and Siberian huskys appeared at an increased risk of T cell lymphoma 92 
(Modiano, et al., 2005). The significance of this is important as immunophenotype has been 93 
reported as an important prognostic variable in canine lymphoma (Dobson, et al., 2001).  94 
 95 
Recent phylogenetic mapping of the canine genome (von Holdt, et al., 2010) has allowed 96 
greater understanding of the domestication of dogs and may provide a useful framework 97 
within which “at risk” breeds can be associated for further genetic analysis. A more recent 98 
analysis focussing on breed associated risk for diagnosis of lymphoma has identified different 99 
“at risk” breeds depending on the European country of origin (Comazzi, et al., 2018). 100 
 101 
Mellanby et al. (2002) reported that the most commonly used tests to diagnose lymphoma in 102 
primary-care practice in the UK were fine needle aspiration (FNA) or biopsy of peripheral 103 
lymph nodes. Within this study it was reported that often both tests were performed. 104 
Following diagnosis, the majority of these animals were reported as receiving some type of 105 
treatment for their lymphoma. When looking at the number of dogs referred, 68% of the 106 
primary-care clinicians had never referred a dog with lymphoma (Mellanby, et al., 2002). 107 
 108 
This present study had 3 main objectives; (1) to estimate the incidence of lymphoma in dogs 109 
presenting to primary-care practice, (2) describe presenting signs and clinical investigations 110 
performed and (3) to identify risk factors for diagnosis of lymphoma in dogs within this 111 
primary-care population. 112 
 113 
Materials and Methods 114 
 115 
The study included a retrospective cohort of all dogs attending an available subset of 116 
VetCompass™ participating practices during 2013 (Vet Compass, 2017). Anonymised 117 
electronic patient records (EPR) were included from dogs under primary veterinary care 118 
between January and December 2013. Ethics approval was provided by the XXXX XXXX XXXX’s 119 
Ethics and Welfare Committee (XXXXX) and the XXXXX XX XXXXX’s Ethics and Welfare 120 
Committee (XXXXXX).  121 
 122 
Potential cases were identified from the electronic database by searching for terms 123 
associated with lymphoma within the clinical notes (lympho*, lymphoma, lymphosarcoma, 124 
LSA, B-cell, T-cell and Immunophenotype) and treatments (vinc*, doxo*, cyclop* and 125 
lomust*). The full clinical records of these potential cases were then manually assessed by a 126 
single assessor to confirm whether they met the inclusion criteria.  127 
 128 
Cases were included for the study if; the attending clinician had made a diagnosis of 129 
lymphoma based on history and clinical signs, with or without laboratory confirmation. A sub-130 
group was identified that had a laboratory diagnosis. Cases were included if lymphoma had 131 
been diagnosed using cytology from fine needle aspirates, histopathology of biopsies or using 132 
the Canine Lymphoma Blood test (Avacta). Cases were excluded from analysis if: i) they had 133 
been diagnosed with lymphoma prior to January 2013, ii) if a diagnosis of leukaemia could 134 
not be excluded within the laboratory confirmed group and/or iii) if a case was reported as 135 
being seen at a practice as a second opinion. All dogs within the year assessed that were not 136 
identified as potential lymphoma cases based on the search terms were included in the 137 
analysis as non-cases. 138 
 139 
From included cases, data on the diagnostic tests undertaken, clinical signs and anatomical 140 
location of lymphoma were all extracted from the EPRs based on either automatic recording 141 
by database software or following manual assessment from the clinical records, and 142 
descriptive analysis performed. Clinical notes were assessed as to whether dogs were 143 
recorded as hypercalcaemic, defined as a total or ionised calcium greater than the reference 144 
range, at presentation. Whether the case was referred for advanced clinical management of 145 
lymphoma was also noted as part of the study.  146 
 147 
Breeds were categorised as a variable using VeNom standardised breed terms (VeNom coding 148 
group, 2017). Purebreeds were grouped into types as defined by the Kennel Club (Kennel 149 
Club, 2017). Any dog that was classified as a breed cross or a designer breed was classified as 150 
a “crossbreed”. A designer breed incorporated a cross breed with a standard name (e.g. 151 
lurcher). Pure and designer breeds were identified individually where 3 or more dogs of that 152 
breed had been included as cases. Pure breeds with less than 3 dogs included were grouped 153 
as “other”. Sex and neuter status were included in the risk analysis with male neutered dogs 154 
used as the baseline for risk analysis. Both sex and neuter status were included in the 155 
univariable analysis due to the interest in neuter association on its own and with the potential 156 
interaction between sex and neuter status. Age and weight were analysed initially as 157 
continuous variables but no linear association was present and so were analysed as 158 
categorised variables. The age (years) at first diagnosis of lymphoma was calculated and 159 
categorised into 4 groups, formulated around the reported median age of diagnosis based on 160 
previously published literature (Yau et al., 2017, Dobson et al., 2001, Edwards et al., Pastor et 161 
al., 2009): < 5, 5 to < 8, 8 to < 12 and ≥ 12 years. Dogs with ages of < 5 years were used as the 162 
baseline value for risk factor analysis. Maximum recorded bodyweight (kg) during 2013 was 163 
categorised into 4 groups: < 10, 10 - < 20, 20 - < 30 and ≥ 30 for ease of analysis. Any missing 164 
values were included into an additional unknown group. Dogs in the 10 - < 20 kg groups were 165 
used as the baseline for risk factor analysis to reflect the category with the median 166 
bodyweight of the reference population.  167 
 168 
All data were exported to a spreadsheet, cleaned and duplicates removed in Excel (Microsoft 169 
Corp.) before transferring into Stata Version 13.1 for analysis (Stata Corp.). Descriptive 170 
statistics were generated for the case and non-case dogs within the study population. 171 
Quantitative data were assessed graphically for normality and summarised with the median 172 
(interquartile range, IQR) or mean (standard deviation, SD). Categorical data were 173 
summarised with number (%).  174 
 175 
Annual incidence risk with 95% confidence intervals (CI) was estimated by calculating the 176 
proportion of incident cases within the total study cohort that were under veterinary care 177 
during 2013 (n=455,553). Specific breed incidences were also estimated by calculating the 178 
proportion of incident cases of a specific breed within the total study population of the same 179 
breed. The CI estimates were derived from standard errors based on approximation to the 180 
normal distribution (Kirkwood & Sterne, 2003). 181 
  182 
Logistic regression modelling was used to identify potential risk factors associated with a 183 
diagnosis of lymphoma with separate models created for all cases and also for those cases 184 
with a confirmed laboratory diagnosis. In the univariable analysis, variables with a likelihood 185 
ratio test (LRT) of p < 0.20 were carried forward to the multivariable model. A forward 186 
stepwise manual approach was used to build the multivariable model to find the variables 187 
associated with a diagnosis of lymphoma (P<0.05). A 20% change in the odds ratio when the 188 
subsequent variable was added to the model was used to identify potentially confounding 189 
variables (Dohoo et al, 2010). Assessment for multicollinear variables was achieved by 190 
checking that two variables have a correlation coefficient r <0.08 as well as looking at the size 191 
of the standard errors and confidence intervals of the variable coefficients (Katz, 2011). Only 192 
one variable would be included into the multivariable model in the situation of 193 
multicollinearity. Plausible interactions were examined with the likelihood test of 194 
homogeneity. Age and weight were assessed for linearity using the likelihood ratio test for 195 
departure from trend and likelihood ratio test for extra-linear effect. Model fit was assessed 196 
both with the Hosmer-Lemeshow test and calculating the area under the ROC curve (Hosmer 197 
Jr, et al., 2013). Statistical significance was set at p < 0.05. 198 
 199 
Multiple a priori sample size calculations were performed to ensure adequate power for each 200 
study aim. For incidence estimation, an analysis required 54,000 dogs to estimate the 201 
incidence risk of lymphoma in UK dogs with an expected frequency of 100/100,000 dogs per 202 
year and a margin of error of 0.01%. It was also estimated a study with 2,150 dogs of a specific 203 
breed accounting for 1% of the denominator study population and 40,880 crossbred dogs 204 
would be required to detect breed as a risk factor of being diagnosed with lymphoma, with 205 
odds ratio of 2.0 or greater (80% power and 95% confidence).  (Centers for Disease Control 206 




The study population consisted of 455,553 dogs under care at 34 veterinary clinics across the 211 
UK. There were 1,991 potential cases identified for manual review; 286 dogs were identified 212 
with a clinical presentation most consistent with lymphoma of which 193 dogs had a 213 
laboratory confirmed diagnosis. The annual incidence risk was estimated as 63/100,000 dogs 214 
per year (95% CI 55.72-70.49) overall with an incidence of 42/100,000 dogs per year (95% CI 215 
36.60-48.78) estimated in laboratory confirmed cases. 216 
 217 
For dogs with a laboratory confirmed diagnosis, diagnosis was made by cytology following 218 
FNA in 123 (64%) cases, 73 (38%) had a biopsy and 10 (5 %) had a diagnosis based on the 219 
Canine Lymphoma Blood Test (CLBT) (Avacta). Some dogs had more than one laboratory test 220 
performed to establish a diagnosis. When considering staging modalities used, forty-one 221 
(14%) dogs had radiography performed as part of their investigations and 42 dogs (15%) had 222 
ultrasound performed. One doghad a bone marrow biopsy (Figure 1).  223 
 224 
The most common anatomical form of lymphoma was multicentric with 233 (83%) of cases 225 
overall and 144 cases (78%) of the laboratory confirmed cases. The next largest anatomical 226 
form within the laboratory confirmed group were the cutaneous form with 18 cases (9%) and 227 
the alimentary form with 10 cases (6%). Thirty-nine (13%) cases had immunohistochemistry 228 
with one case immunophenotyped using PARR, 22 cases (56%) were diagnosed with B cell 229 
lymphoma and 17 cases (44%) with T cell lymphoma. Of these there were 19 multicentric B 230 
cell lymphomas reported and 3 multicentric T cell  lymphomas. All cutaneous forms that had 231 
immunohistochemistry were T cell lymphomas (n=9). The two mediastinal lymphomas that 232 
were immunophenotyped were B cell. Both of the alimentary lymphomas that were 233 
immunophenotyped were T cell. The case immunophenotyped using PARR was reported as 234 
an indolent alimentary lymphoma. Twenty-two cases of the 73 cases diagnosed following a 235 
biopsy (30%) had records relating to tumour grade. Of these 16 (73%) were described as high 236 
grade or large cell and 6 (27%) were described as low grade, small cell or indolent. 237 
 238 
Overall, the most common presenting sign, as recorded in the clinical notes, was 239 
lymphadenopathy with 236 dogs presenting with lymphadenopathy (83%). This was followed 240 
by lethargy in 94 dogs (33%), weight loss in 47 dogs (16%), hyporexia/anorexia in 46 dogs 241 
(16%), vomiting in 37 dogs (13%), polyuria and/or polydipsia in 31 dogs (11%) and coughing 242 
present in 28 dogs (10%). Only 17 cases (6%) were documented as being hypercalcaemic. The 243 
majority of cases presented with a combination of clinical signs but no dominant combination 244 
was present on subjective analysis of the data. 245 
 246 
Median age overall at diagnosis was 9 years (IQR 7-12) with a younger median age of 8 years 247 
(IQR 6-11) in those with a laboratory confirmed diagnosis. 127 (44%) of the dogs with 248 
lymphoma were female and 158 (56%) were male, of which 80 (63%) and 81 (51%) 249 
respectively were neutered at the time of diagnosis. In those with a laboratory confirmed 250 
diagnosis 87 (45%) were female and 112 (58%) of those were neutered. Eighteen cases (6%) 251 
were noted as being referred based on manual assessment of clinical records. One hundred 252 
and eighteen dogs (41%) were euthanized following diagnosis without further treatment, 104 253 
dogs (36%) were treated with palliative prednisolone and 55 dogs (19%) received 254 
chemotherapy. Fifteen out of the 18 cases referred were treated with chemotherapy and of 255 
these nine received a CHOP based protocol. 256 
 257 
Individual breeds with the highest incidence risk of lymphoma included Scottish terriers 258 
(436/100,000 dogs per year, 95% CI 119-1113), dogue de Bordeaux (272/100,000 per year, 259 
95% CI 88-633), bull terriers (256/100,000 per year, 95% CI 83 - 596) and boxers (242/100,000 260 
per year, 95% CI 136 - 399) (see Table 1). 261 
 262 
Univariable analysis identified age, neutering status, bodyweight and breed all being strongly 263 
associated with increased risk of diagnosing lymphoma overall. Dogs aged ≥ 12 years had the 264 
highest odds of developing lymphoma when compared to the baseline (OR 11.74, 95% CI 7.81-265 
17.65). Neutered dogs had increased odds of being diagnosed with lymphoma compared to 266 
those that were entire (OR 1.92, 95% CI 1.46-2.53) with entire females having the lowest odds 267 
(0.28, 95% CI 0.15-0.51). Heavier dogs (≥ 30kg) had increased odds of being diagnosed with 268 
lymphoma than those between 10 - < 20kg (OR 1.54 95% CI 1.14-2.01). Overall increased odds 269 
were observed for Scottish terriers, bull terriers, boxers, dogue de Bordeaux, lurchers and 270 
West Highland white terriers, rottweilers and golden retrievers (Table 2) The Kennel Club 271 
group with the highest odds for a diagnosis was the working group (OR 2.07 95% CI 1.39-272 
3.08). 273 
 274 
Age, breed and bodyweight were included in the multivariable analyses. Increasing odds were 275 
observed in increasing age groups. Overall, the highest risk group was found to be the oldest 276 
age group (≥ 12 years of age) with over 10 times the odds compared to the youngest age 277 
group (OR 10.20, 95% CI 6.72-15.48). Odds of lymphoma increased with increasing 278 
bodyweight with the heaviest group (≥ 30kg) having an increased odds of lymphoma 279 
compared to the baseline 10-20kg group (OR 1.56, 95% CI 1.06-2.30). No linear or extra-linear 280 
association of age or weight were found. There were no interactions or multicollinearity 281 
between variables. Scottish terriers, dogue de Bordeaux, bull terriers, West Highland white 282 
terriers and boxers all had increased odds of diagnosis of lymphoma when compared to 283 
crossbred dogs (Table 3). Additionally, when looking at the laboratory confirmed cases, 284 
schnauzers that previously had a non-significant increased odds ratio became significantly at 285 
risk. The associations of sex and neuter status with lymphoma were confounded by age.  After 286 
accounting for age, these two variables were no longer statistically significant and were 287 
therefore were not retained in the multivariable model. Age was retained in the model as the 288 
confounder and variable of interest. No further confounders were identified.  289 
 290 
 291 
  292 
Discussion 293 
 294 
The study aimed to apply inclusion criteria to reflect as closely as possible the epidemiological 295 
picture of canine lymphoma as it presents and is recorded in primary-care practice in the UK 296 
assuming that many cases may not be fully clinically investigated and that the decision to 297 
euthanize may often be made based heavily on clinical signs. The overall incidence of 63/ 298 
100,000 dogs per year falls within the range previously reported for canine lymphoma with 299 
an incidence of between 7-122/ 100,000 dogs per year (Edwards, et al., 2003; Pastor, et al., 300 
2009; Mellanby, et al., 2002). This number drops but not excessively to 42/ 100,000 dogs per 301 
year when considering the laboratory confirmed cases. The most common presenting clinical 302 
signs are similar to those previously reported; lymphadenopathy, lethargy, weight loss, 303 
anorexia (Zandvliet, 2016).  304 
 305 
The VetCompassTM programme allows for analysis of clinical records for epidemiological 306 
studies that aim to reduce selection and reporting biases that limit other study designs based 307 
on questionaires, referral data and cancer registries (O'Neill, et al., 2014). The benefit of using 308 
this method to collect and analyse data is to reduce potential bias that may be implicit when 309 
sending out questionaires, such as Mellanby et al (2002),. This study sent out questionaires 310 
to 1000 randomly selected first opinion practices. This method, like the one used in our study, 311 
eliminated the bias of selecting only practices that usually refer dogs with lymphoma to 312 
referral centres. However this cannot limit the bias that can be caused by the population 313 
described by responders to the questionaire versus those who do not respond.  314 
 315 
The most common anatomical presentation of lymphoma identifed in this study was 316 
multicentric. The high proportion (83%) of cases presenting with multicentric lymphoma, 317 
whilst to be expected given the reported prevalence of this type of lymphoma (Zandvliet, 318 
2016), also can reflect some of the limitations of this study. The anatomical classification was 319 
reliant either on the veterinary surgeon recording the diagnosis within the clinical notes or 320 
based on the assessor’s interpretation of the clinical records. Inconsistencies within the 321 
clinical notes or the lack of further investigations meant that some other anatomical forms of 322 
lymphoma may have been missed or misclassified.  323 
 324 
The types of diagnostic and staging investigations used to confirm a diagnosis of lymphoma 325 
were similar to those previously reported by Mellanby et al (2002). Fine needle aspiration 326 
(63%) and biopsies (38%) were the most commonly used modalities. Only 41 (14%) dogs had 327 
radiography performed and 42 dogs (15%) had ultrasonography. Further to this, only 39 (13%) 328 
cases had immunophenotyping performed, which is interesting because immunophenotype 329 
could inform prognosis as described by Dobson et al. (2001), Marconato et al. (2011) and Rao 330 
et al. (2011) and potentially influence selection of treatment protocol. Whilst not directly 331 
impacting on risk factors, immunophenotype may be associated with certain types of 332 
lymphoma or certain breeds and so may indirectly influence risk for developing the disease 333 
(Dobson, et al., 2001). The low numbers of cases that had immunophenotyping may also 334 
reflect the number of dogs treated with chemotherapy, as these are the most likely cases to 335 
have had immunophenotyping as part of their investigations.  336 
 337 
The number of investigations in these cases may reflect the realities of diagnosing and 338 
managing canine lymphoma within primary-care practice but also highlights a potential need 339 
for further education of practitioners as to the opportunities and significance of different 340 
diagnostics available and their relevance as to prognosis when deciding on appropriate 341 
therapy. The number of investigations are likely to be underestimated as investigations 342 
carried out at referral practices or other practices were not recorded unless recorded within 343 
the clinical text. An example of this is the recording of grade of lymphoma when a biopsy had 344 
been performed, this was only available for 30% of the cases assessed. This highlights 345 
potentially both a limitation and an observation from this study which is that even following 346 
a biopsy there were only a relatively low number of lymphomas (30%) where a grade was 347 
reported. This is potentially explained by the lack of recording of lymphoma grade within the 348 
clincial notes but possibly highlights another area where further education of primary-care 349 
practioners may alter their approach to the diagnosis and classifying of theses lymphomas, 350 
especially given the better prognosis that can be seen with some of the more indolent forms 351 
of the disease. It is possible now that with the advent of newer molecular techniques available 352 
to primary-care practices that this may have changed and that there is now a difference in 353 
the investigations carried out within primary-care practice when compared to the time period 354 
seen in this study. 355 
 356 
Whilst the univariable analysis identified sex and neutering status as associated with an 357 
increased risk of developing lymphoma as previously reported by Belanger et al (2017) and 358 
Yau et al (2017), these potential risk factors did not reach significance when included in the 359 
multivariable analysis in this study, highlighting the continued importance of multivariable 360 
analysis in trying to eliminate confounding variables that may have been present in older 361 
studies. The multivariable analysis identified age, bodyweight and breed as risk factors within 362 
our population for the development of lymphoma: cases older than 12 years were at highest 363 
risk, although interestingly, when only laboratory confirmed cases were analysed, the odds 364 
reduced to a similar odds ratio to the 8-12 year old group, as reported by Edwards et al (2003) 365 
and Yau et al (2017). It is possible that this reflects the increased likelhood of primary-care 366 
practioners to consider a diagnosis of lymphoma without laboratory confirmation in older 367 
patients. It should be considered that categorisation of age results in the assumption that the 368 
effect measure is equal across each category which may not always be the case (Altman et al 369 
2006). However the categories used were intended to represent different general age groups 370 
of dogs based on previous studies and to aid the clinical interpretation of the association with 371 
age. 372 
 373 
The increased risk of  lymphoma diagnosis associated with increased bodyweight at diagnosis 374 
is interesting. Though breed and bodyweight are likely to be related, they were not found to 375 
be highly correlated in analysis and the model remained stable when both were included. The 376 
weight variable may be incorporating a size element that is not encompassed by breed and 377 
therefore a genetic basis. Increased body mass index whilst young has been shown to be 378 
associated with increased risk of developing certain types of lymphoma in later life in humans; 379 
including diffuse large B cell lymphoma, the most commonly occuring type of lymphoma 380 
reported in dogs (Chihara, et al., 2015). However, this finding may be biased by the type of 381 
breed, with some breeds e.g. dogue de Bordeaux and rottweiler naturally being heavier than 382 
others. This will always be considered an issue when multiple dog breeds are being included 383 
in analysis and represent the phenotypic range of sizes seen in domestic dogs. Whilst 384 
individual anlaysis of breeds would allow a more accurate assessment of weight within a 385 
single breed and its association with developing lymphoma, it is likely that acquiring the 386 
number of cases to achieve statistical significance would be difficult. It would be interesting 387 
in any future studies to look at body condition score as a more accurate risk factor, thereby 388 
reducing some of the inherent bias introduced by looking at different breeds. Unfortunately 389 
such analysis was beyond the scope of this study.  390 
 391 
Previously a number of different breeds have been associated with increased risk of 392 
developing lymphoma including boxers, bulldogs, bull mastiffs, rottweilers and golden 393 
retrievers (Edwards, et al., 2003; Modiano, et al., 2005; Yau, et al., 2017). Our study also 394 
identified increased risk of developing lymphoma in breeds such as bull terriers, Scottish 395 
terriers and West Highland white terriers as well as the previously reported breeds. When 396 
considering the breed types identified by von Holdt et al. (2010) it is interesting that the breed 397 
groups to which the majority of these dogs belong are closely located on the phylogenetic 398 
tree. It is possible that further genetic analysis ofgroups could offer insight into the genetic 399 
aetiology or predisposition of lymphoma in dogs. However this may be a gross simplification 400 
of what is actually an aetiologically diverse and complicated group of diseases which also may 401 
have a significant environmental component to the development of the disease. There is the 402 
further complication that there are variations in risk associated with different breeds in 403 
different countries (Comazzi, et al., 2018). 404 
 405 
The retrospective nature of the study meant that there were several incomplete variables 406 
that would have potentially added more scope to the risk factor analysis. This combined with 407 
the high case numbers needing to be manually assessed means that it is possible staging and 408 
other factors indicating a diagnosis of lymphoma may be missed leading to under-reporting 409 
of clinical signs or diagnostics performed. It is also possible that the risk factor analysis was 410 
underpowered when considering certain breed susceptibility due to the low number of dogs 411 
per breed that had a diagnosis of lymphoma, an obvious example of this being the incidence 412 
and breed susceptibility of Scottish terriers that had an incidence of 436 with a very wide 413 
confidence interval (119-1113) and an odds ratio of 4.78(95% CI 1.72-13.34). This is very likely 414 
a reflection of the small number of Scottish terriers recorded in the study (n=4) and highlights 415 
the difficulties inherent in this type of study that despite recording a large number of total 416 
cases, a single breed analysis can still yield very small numbers, and caution should be used 417 
when interpreting the results. 418 
 419 
As previously mentioned, body condition score would have probably been a better assessor 420 
of the significance of being overweight with respect to the risk of developing lymphoma. 421 
Further, it should be noted, maximum body weight was elected as many cases did not have a 422 
weight recorded on the date of diagnosis and for non-cases there was not always an 423 
equivalent date of diagnosis, such that maximum weight was considered the most consistent 424 
measure of comparison. However this type of analysis is always going to be limited by the 425 
breadth of information provided in the clincial records and there were large variations in 426 
detail and content present within the records analysed. One of the consequences or 427 
reflections of this is that this study was looking for cases with “lymphoma.” Given that 428 
lymphoma reflects a wide variety of different conditions within the canine population, and 429 
often the investigations required to distinguish these conditions can be quite extensive, this 430 
study can only ever report on generalities observed. Hopefully this study can add to the 431 
evidence base for future studies looking to analyse the epidemiology of canine lymphoma.  432 
 433 
There was not an obvious difference in populations between all included cases and the sub-434 
group that had a laboratory confirmed diagnosis, nor was there an observed difference when 435 
other studies were subjectively assessed for similarities. This may be an underestimation as 436 
cases where referral centres were consulted for advice were not identified within this group 437 
andit was not always possible to assess from the clinical notes whether a dog was referred. 438 
The incidence, breeds and clinical signs reported were similar to those which have previously 439 
been reported. No new at risk breeds were identified overall that were not present in the 440 
laboratory confirmed cases. This would indicate that even with the broadest of inclusion 441 
criteria, there was not a different, previously unidentified group of dogs  within the primary-442 
care population.  443 
 444 
Further analysis of outcomes within this same population of dogs would allow further 445 
interrogation of the cases identified as it was noted that treatment of these animals did vary. 446 
Survival analysis dependent on breed, presenting signs and treatment given would add to the 447 
evidence base for primary-care practioners. There are possible genetic links that could be 448 
explored further and the breeds identified should have further scrutiny as to the type of 449 
lymphoma that they developed. 450 
 451 
This study concluded that the incidence of canine lymphoma was 63 cases/ 100,000 dogs per 452 
year, with an incidence of laboratory confirmed cases of 42 cases/ 100,000 dogs per year. 453 
Age, bodyweight and breed were all considered significantly associated with increased risk of 454 
developing lymphoma. The suspected at risk breeds, although there were low numbers of 455 
dogs within each individiual breed, following multivariate analysis, were Scottish terriers, 456 
dogues de Bordeaux, bull terriers, West Highland white terriers, schnauzers and boxers. These 457 
results can, with the previous studies already published, add to the evidence base for primary-458 
care practioners when considering dogs that present with clinical signs consistent with 459 
lymphoma. 460 
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